|Three Months Ended|
|Sept. 30,||Jun. 30,||Sept. 30,|
|USD millions, except per share data||2012||2012||2011|
|Earnings per share||0.40||0.40||0.46|
Net income for the September 2012 quarter was $71.3 million or $0.40 per share, compared with $72.0 million, or $0.40 per share, for the June 2012 quarter and $80.5 million, or $0.46 per share, for the September 2011 quarter.“Despite challenging global economic conditions and growing uncertainty in end markets, Molex continues to introduce new products driving growth higher than the overall connector market. With our reputation for quality, customer service and engineering, Molex is recognized as an industry leader and increasingly the supplier of choice as our customers continue to require innovative interconnect solutions,” commented Martin P. Slark, Chief Executive Officer. “We have been expanding our M&A efforts over the past year and are pleased to announce that we acquired Affinity Medical Technologies in early October. Affinity manufactures custom medical interconnect products and systems and will complement our strategy of focusing on high growth markets.” Other financial highlights for the quarter ended September 30, 2012:
- Gross profit margin was 29.3%, compared with 30.0% in the June 2012 quarter and 31.3% in the September 2011 quarter. The current quarter gross margin was impacted by start-up costs and product mix related to new programs launched in the quarter.
- SG&A expense was $163.1 million, compared with $161.6 million in the June 2012 quarter and $169.2 million in the September 2011 quarter. SG&A expense included insurance proceeds of $9.9 million ($0.03 per share) in the September 2012 quarter and $6.0 million ($0.02 per share) in the June 2012 quarter related to losses incurred from the March 2011 earthquake and tsunami in Japan.
- Backlog was $445.3 million, an increase of 6.9% from the June 2012 quarter and 15.0% from the September 2011 quarter. These increases are the result of orders for new products that were launched in the September 2012 quarter.
- Capital expenditures were $69.4 million or 7.6% of revenue.
- Inventory days outstanding was 84 days compared with 87 days in the June 2012 quarter and 84 days in the September 2011 quarter.
- Accounts receivable days outstanding was 69 days compared with 70 days in the June 2012 quarter and 69 days in the September 2011 quarter.
- The effective tax rate was 30.8%.
- Cash dividends paid were $0.22 per share, an increase of 10% from the June 2012 quarter.
Earnings Conference Call InformationA conference call will be held on Tuesday, October 23, 2012 at 8:30 a.m. central time. Please dial (888) 679-8018 to participate in the call. International callers should dial (617) 213-4845. Please dial in at least five minutes prior to the start of the call and refer to participant pass code 14202097. Internet users will be able to access the webcast, including slide materials, live and in replay in the “Investors” section of the Company’s website at www.molex.com. A 48-hour telephone replay will be available at approximately 10:30 a.m. central time at (888) 286-8010 or (617) 801-6888 / pass code 84134444. Other Investor Events Nov. 14, 2012 – UBS Global Technology Conference in New York Dec. 04, 2012 – NASDAQ OMX 29 th Investor Program in London Forward-Looking Statements Statements in this release that are not historical are forward-looking and are subject to various risks and uncertainties that could cause actual results to vary materially from those stated. Words such as “expect,” “anticipate,” “outlook,” “forecast,” “could,” “project,” “intend,” “plan,” “continue,” “believe,” “seek,” “estimate,” “should,” “may,” “assume,” “potential,” variations of such words and similar expressions are used to identify these forward-looking statements. Forward-looking statements are based on currently available information and include, among others, the discussion under “Outlook.” These statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions that are difficult to predict. Respective risks, uncertainties, and assumptions that could affect the outcome or results of operations are described in Part 1, Item 1A of our Annual Report on Form 10-K for the year ended June 30, 2012, which is incorporated by reference and in other reports that Molex files or furnishes with the Securities and Exchange Commission. We have based our forward-looking statements on our management’s beliefs and assumptions based on information available to management at the time the statements are made. We caution you that actual outcomes and results may differ materially from what is expressed, implied, or forecast by our forward-looking statements. Reference is made in particular to forward-looking statements regarding growth strategies, industry trends, global economic conditions, success of customers, cost of raw materials, value of inventory, availability of credit, foreign currency exchange rates, labor costs, protection of intellectual property, cost reduction initiatives, acquisition synergies, manufacturing strategies, product development introduction and sales, regulatory changes, competitive strengths, income tax fluctuations, natural disasters, unauthorized access to data, government investigations and outcomes of legal proceedings. Except as required under the federal securities laws, we do not have any intention or obligation to update publicly any forward-looking statements after the distribution of this report, whether as a result of new information, future events, changes in assumptions, or otherwise. Molex Incorporated is a 74-year-old global manufacturer of electronic, electrical and fiber optic interconnection systems. Based in Lisle, Illinois, USA, the Company operates 41 manufacturing locations in 16 countries. The Molex website is www.molex.com. Editor’s note: Molex is traded on the NASDAQ Global Select Market (MOLX and MOLXA) in the United States and on the London Stock Exchange. The Company’s voting common stock (MOLX) is included in the S&P 500 Index.
|Condensed Consolidated Balance Sheets|
|Sept. 30,||June 30,|
|Cash and cash equivalents||$||685,972||$||637,417|
|Accounts receivable, less allowances of $37,401 and $37,876, respectively||770,976||751,279|
|Deferred income taxes||109,101||110,789|
|Other current assets||38,341||33,098|
|Total current assets||2,184,878||2,079,238|
|Property, plant and equipment, net||1,178,875||1,150,549|
|Non-current deferred income taxes||52,653||50,038|
|LIABILITIES AND STOCKHOLDERS’ EQUITY|
|Current portion of short-term borrowings and long-term debt||$||75,074||$||104,933|
|Accrual for unauthorized activities in Japan||189,040||184,177|
|Income taxes payable||49,828||35,360|
|Total current liabilities||954,469||891,996|
|Other non-current liabilities||19,321||18,174|
|Accrued pension and other postretirement benefits||113,847||115,176|
|Commitments and contingencies|
|Total stockholders’ equity||2,508,241||2,436,125|
|Total liabilities and stockholders’ equity||$||3,745,878||$||3,611,503|
|Condensed Consolidated Statements of Income|
|(in thousands, except per share data)|
|Three Months Ended|
|Cost of sales||648,504||643,257|
|Selling, general and administrative||163,121||169,225|
|Unauthorized activities in Japan||2,561||2,922|
|Total operating expenses||165,682||172,147|
|Income from operations||102,735||120,581|
|Interest (expense), net||(810||)||(1,391||)|
|Total other income (expense), net||386||(1,115||)|
|Income before income taxes||103,121||119,466|
|Earnings per share:|
|Dividends declared per share||$||0.2200||$||0.2000|
|Average common shares outstanding:|
|Condensed Consolidated Statements of Cash Flows|
|Three Months Ended|
|Add non-cash items included in net income:|
|Depreciation and amortization||57,742||61,239|
|Other non-cash items||3,767||5,991|
|Changes in assets and liabilities:|
|Other current assets and liabilities||4,326||28,890|
|Other assets and liabilities||11,331||(25,188||)|
|Cash provided from operating activities||167,404||150,549|
|Proceeds from sales of property, plant and equipment||1,914||1,396|
|Proceeds from sales or maturities of marketable securities||3,168||4,868|
|Purchases of marketable securities||(4,099||)||(2,777||)|
|Insurance proceeds and other investing activities||9,722||-|
|Cash used for investing activities||(58,708||)||(39,317||)|
|Proceeds from revolving credit facility||10,000||30,000|
|Payments on revolving credit facility||(10,000||)||(195,000||)|
|Payments on short-term loans and debt||(31,611||)||(27,409||)|
|Proceeds from issuance of long-term debt||-||150,000|
|Cash dividends paid||(38,827||)||(35,068||)|
|Exercise of stock options||1,715||620|
|Other financing activities||(1,026||)||(1,014||)|
|Cash used for financing activities||(69,749||)||(77,871||)|
|Effect of exchange rate changes on cash||9,608||(8,584||)|
|Net increase in cash and cash equivalents||48,555||24,777|
|Cash and cash equivalents, beginning of period||637,417||532,599|
|Cash and cash equivalents, end of period||$||685,972||$||557,376|